Company intelligence / Profile preview

415 Capital

Munich, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

415 Capital is a leading specialist venture capital firm, investing in breakthrough medical technology startups at clinical and commercial stages, with a focus on cardiovascular and neurovascular innovation. Their portfolio includes companies advancing minimally invasive, device-based solutions; collectively, 50+ startups backed by 415 Capital are in use by physicians to treat hundreds of thousands of patients annually[1][4][5][6].

Therapeutic areas: NeurologyCardiovascular
Modalities: DeviceSurgical Robotics
Industry: Investors

Partnerships

Uniphar PLCCoRRect Medical GmbHCordis (strategic partner for Endovascular Engineering)

Beyond the preview

Go deeper on 415 Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 415 Capital.

Explore the full profile